Quarterly report · Q3
7459.TEDINET S100SUGP
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.71T | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥3.36T | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.57T | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥37.2bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥37.5bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥50.2bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥65.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥49.9bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥53.7bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥56.7bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥28.3bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥38.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥29.8bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥36.7bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥37.1bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥1.87T | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥1.71T | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥1.81T | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.16T | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥1.02T | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥712.6bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥688.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥678.0bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥214.7bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥195.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥133.19 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.8 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥184.82 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥142.16 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.65 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥179.12 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥136.4 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 31.0% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥2.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥2.2bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥30m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥86.7bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥86.7bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥1m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.3bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥883.0bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥882.8bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥231m |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥22.0bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥1.75T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥1.75T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥2.0bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥13.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥2.72T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥2.71T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥2.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥37.2bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥7.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥7.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | ¥44m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥56.2bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥56.2bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.2bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥848.2bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥847.9bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥253m |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥19.1bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.67T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.66T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥6.7bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥2.57T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥2.57T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥37.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 385
| Item | Context | Value | Unit |
|---|---|---|---|
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 8590000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 1663237000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 847942000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleAndRelatedBusinessReportableSegmentsMember | 56238000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 2567418000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 2567418000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 6695000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 253000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleAndRelatedBusinessReportableSegmentsMember | 2000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 6951000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -6951000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 1669933000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 848195000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleAndRelatedBusinessReportableSegmentsMember | 56240000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 2574369000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -6951000000 | JPY |
| Net sales | Prior1YTDDuration | 2567418000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 16219000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 19110000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleAndRelatedBusinessReportableSegmentsMember | 2157000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 37487000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | 44000000 | JPY |
| Operating income | Prior1YTDDuration | 37531000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 1745419000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 882810000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleAndRelatedBusinessReportableSegmentsMember | 86686000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 2714915000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 2714915000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 1977000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 231000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleAndRelatedBusinessReportableSegmentsMember | 1000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 2211000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -2211000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 1747397000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 883042000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleAndRelatedBusinessReportableSegmentsMember | 86688000000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 2717127000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -2211000000 | JPY |
| Net sales | CurrentYTDDuration | 2714915000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02632-000PrescriptionPharmaceuticalWholesaleBusinessReportableSegmentsMember | 13008000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02632-000CosmeticsDailyNecessitiesReportableSegmentsMember | 21968000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02632-000AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleAndRelatedBusinessReportableSegmentsMember | 2267000000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 37245000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -30000000 | JPY |
| Operating income | CurrentYTDDuration | 37215000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |